PortfoliosLab logoPortfoliosLab logo
STGW vs. BVS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

STGW vs. BVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Stagwell Inc. (STGW) and Bioventus Inc. (BVS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, STGW achieves a 37.22% return, which is significantly higher than BVS's 17.07% return.


STGW

1D
0.75%
1M
7.88%
YTD
37.22%
6M
29.54%
1Y
56.05%
3Y*
-4.02%
5Y*
10Y*

BVS

1D
1.99%
1M
-20.38%
YTD
17.07%
6M
16.29%
1Y
35.46%
3Y*
40.14%
5Y*
-13.07%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

STGW vs. BVS - Yearly Performance Comparison


2026 (YTD)20252024202320222021
STGW
Stagwell Inc.
37.22%-25.68%-0.75%6.76%-28.37%32.77%
BVS
Bioventus Inc.
17.07%-29.14%99.24%101.92%-81.99%-2.09%

Correlation

The correlation between STGW and BVS is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.23

Correlation (All Time)
Calculated using the full available price history since Aug 3, 2021

0.24

Fundamentals

Market Cap

STGW:

$1.68B

BVS:

$609.77M

EPS

STGW:

$0.07

BVS:

$0.41

PE Ratio

STGW:

90.73

BVS:

21.12

PEG Ratio

STGW:

0.16

BVS:

0.17

PS Ratio

STGW:

0.58

BVS:

1.04

PB Ratio

STGW:

2.33

BVS:

3.23

Total Revenue (TTM)

STGW:

$2.96B

BVS:

$576.30M

Gross Profit (TTM)

STGW:

$1.07B

BVS:

$390.14M

EBITDA (TTM)

STGW:

$305.16M

BVS:

$98.72M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

STGW vs. BVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

STGW
STGW Risk / Return Rank: 7171
Overall Rank
STGW Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
STGW Sortino Ratio Rank: 7070
Sortino Ratio Rank
STGW Omega Ratio Rank: 7070
Omega Ratio Rank
STGW Calmar Ratio Rank: 7171
Calmar Ratio Rank
STGW Martin Ratio Rank: 7474
Martin Ratio Rank

BVS
BVS Risk / Return Rank: 6666
Overall Rank
BVS Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
BVS Sortino Ratio Rank: 6363
Sortino Ratio Rank
BVS Omega Ratio Rank: 6262
Omega Ratio Rank
BVS Calmar Ratio Rank: 6868
Calmar Ratio Rank
BVS Martin Ratio Rank: 7373
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

STGW vs. BVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Stagwell Inc. (STGW) and Bioventus Inc. (BVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


STGWBVSDifference
Sharpe ratioReturn per unit of total volatility

+0.29

Sortino ratioReturn per unit of downside risk

+0.30

Omega ratioGain probability vs. loss probability

1.21

1.17

+0.05

Calmar ratioReturn relative to maximum drawdown

1.53

1.29

+0.24

Martin ratioReturn relative to average drawdown

4.44

4.18

+0.26

STGW vs. BVS - Sharpe Ratio Comparison

The current STGW Sharpe Ratio is 1.00, which is higher than the BVS Sharpe Ratio of 0.70. The chart below compares the historical Sharpe Ratios of STGW and BVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

STGW vs. BVS - Drawdown Comparison

The maximum STGW drawdown since its inception was -62.11%, smaller than the maximum BVS drawdown of -95.18%. Use the drawdown chart below to compare losses from any high point for STGW and BVS.


Loading charts...

Drawdown Indicators


STGWBVSDifference

Max Drawdown

Largest peak-to-trough decline

-62.11%

-95.18%

+33.07%

Max Drawdown (1Y)

Largest decline over 1 year

-36.78%

-27.51%

-9.27%

Max Drawdown (3Y)

Largest decline over 3 years

-50.92%

-55.22%

+4.30%

Max Drawdown (5Y)

Largest decline over 5 years

-95.07%

Current Drawdown

Current decline from peak

-36.76%

-54.66%

+17.90%

Average Drawdown

Average peak-to-trough decline

-37.95%

-56.33%

+18.38%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.66%

8.51%

+4.15%

Volatility

STGW vs. BVS - Volatility Comparison

The current volatility for Stagwell Inc. (STGW) is 14.79%, while Bioventus Inc. (BVS) has a volatility of 19.57%. This indicates that STGW experiences smaller price fluctuations and is considered to be less risky than BVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


STGWBVSDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.79%

19.57%

-4.78%

Volatility (6M)

Calculated over the trailing 6-month period

41.28%

32.69%

+8.59%

Volatility (1Y)

Calculated over the trailing 1-year period

56.51%

50.69%

+5.82%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

55.43%

81.03%

-25.60%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

55.43%

80.66%

-25.23%

Dividends

STGW vs. BVS - Dividend Comparison

Neither STGW nor BVS has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

STGW vs. BVS - Financials Comparison

This section allows you to compare key financial metrics between Stagwell Inc. and Bioventus Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M20222023202420252026
704.14M
132.09M
(STGW) Total Revenue
(BVS) Total Revenue
Values in USD except per share items

STGW vs. BVS - Profitability Comparison

The chart below illustrates the profitability comparison between Stagwell Inc. and Bioventus Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%20222023202420252026
34.7%
68.7%
Portfolio components
STGW - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Stagwell Inc. reported a gross profit of 244.61M and revenue of 704.14M. Therefore, the gross margin over that period was 34.7%.

BVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported a gross profit of 90.77M and revenue of 132.09M. Therefore, the gross margin over that period was 68.7%.

STGW - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Stagwell Inc. reported an operating income of 9.64M and revenue of 704.14M, resulting in an operating margin of 1.4%.

BVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported an operating income of 8.42M and revenue of 132.09M, resulting in an operating margin of 6.4%.

STGW - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Stagwell Inc. reported a net income of -12.97M and revenue of 704.14M, resulting in a net margin of -1.8%.

BVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported a net income of 3.11M and revenue of 132.09M, resulting in a net margin of 2.4%.


Frequently Asked Questions


STGW and BVS have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BVS has higher volatility (19.57%) compared to STGW (14.79%). In terms of maximum drawdown, STGW dropped -62.11% vs BVS's -95.18%.

STGW currently has the higher Sharpe Ratio (1.00 vs 0.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for STGW and BVS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer